Posted on

McKesson

VN:F [1.9.11_1134]
Rating: 0 (from 0 votes)
The nation’s largest health-care provider greatly expanded its already extensive cancer treatment business when it bought U.S. Oncology for $2.2 billion last December. Still, distribution remains McKesson’s backbone: A full one-third of all medicines used in the U.S. run through its pipeline.The company also is the dominant player in health care information systems. More than 70% of the nation’s big market hospitals use its technology to digitize prescriptions and patient medical records. A class-action lawsuit over wholesale drug prices has cut into profits; still, its stock is up 23% over the past year. —P.N.

source

VN:F [1.9.11_1134]
Customer Service
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Environmental Impact
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Corporate Welfare / Subsidies
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Employee Treatment
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Safety / Health
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Criminal Activity
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Outsourcing
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Community
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Sponsorships
Rating: 0.0/5 (0 votes cast)
VN:F [1.9.11_1134]
Politics
Rating: 0.0/5 (0 votes cast)

About corporatOCRACY

Corporatism meets Democracy; Wall Street meets Main Street.

Leave a Reply

Your email address will not be published. Required fields are marked *


*